This invention relates to an anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient. It was proved that the BEC 1 potassium channel inhibitor has an action to improve learning disorder and is useful as a preventive or therapeutic agent for diseases, preferably dementia, in which the BEC 1 potassium channel is considered to be concerned. Illustratively, it was confirmed by an in vivo test that the BEC 1 potassium channel inhibitor has an action to improve learning disorder. Also, it was found that a compound having 2,4,6-triamino-1,3,5-triazine has a BEC 1 potassium channel inhibitory action.
本发明涉及一种使用B
EC 1
钾通道
抑制剂作为活性成分的抗痴呆剂。证明了B
EC 1
钾通道
抑制剂具有改善学习障碍的作用,并且作为预防或治疗剂,特别是在B
EC 1
钾通道被认为与疾病,尤其是痴呆症有关的情况下具有用处。例如,通过体内试验证实了B
EC 1
钾通道
抑制剂具有改善学习障碍的作用。此外,还发现一种具有2,4,6-三
氨基-
1,3,5-三嗪的化合物具有B
EC 1
钾通道抑制作用。